Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000163451 | SCV000213998 | likely benign | Hereditary cancer-predisposing syndrome | 2016-11-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000441943 | SCV000518183 | likely benign | not specified | 2017-05-24 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000471921 | SCV000555961 | likely benign | Hereditary nonpolyposis colorectal neoplasms | 2025-01-24 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000163451 | SCV000911478 | likely benign | Hereditary cancer-predisposing syndrome | 2017-11-30 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003995256 | SCV004840980 | likely benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV005246691 | SCV005896506 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2024-11-22 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |